25
Apr

BioBarica will be present at the Puglia Congress on Rehabilitation

BioBarica will be present at the Puglia Rehabilitation Congress. The event will be held on June 8th at the Hotel The Nicolaus, Bari. Rehabilitation medicine acquires the value of an essential medical discipline every day in the implementation of PDTAs on the world of chronicity. This value is increasingly shared with different specialties and health professionals. The purpose of this

Read more

10
Apr

BioBarica will participate in the ARTHROMEETING

BioBarica will be present at the ARTHROMEETING in Rozzano, Milano. The event will be held at the Humanitas Research Hospital, on April 13th, 2019, starting at 9:00 A.M. The objective of the day is to tackle the functional recovery in the athlete’s knee. The meeting will be under the presidency of doctors Enrico Arnaldi and Piero Volpi. The scientists responsible

Read more

27
Mar

BioBarica is at the XXXVI National FMSI Congress in Rome

BioBarica is at the XXXVI National FMSI Congress in Rome. The event takes place at the “Rome Cavalieri” Hilton Conference Center, from March 27th to 29th, 2019. The objective of the conference is to provide professional training and updating, but it is also a time of fruitful encounter and comparison between all members of the FMSI. This Congress has a

Read more

12
Mar

Sudden sensorineural hearing loss: role of hyperbaric oxygen therapy

Sudden sensorineural hearing loss (SSNHL) is defined as an acute hearing reduction, typically unilateral, of 30 dB or more in at least three consecutive frequencies, occurring within 72 hours of symptom onset. It was first described in 1926 as Citelli’s acute cochlear block and is currently more commonly referred to as idiopathic sudden sensorineural hearing loss (ISSNHL). There are approximately

Read more

26
Feb

Diabetic hand infections and hyperbaric oxygen therapy

According to the World Health Organization (WHO), 346 million people have diabetes worldwide and the number of diabetics is predicted to double between 2005 and 2030. Foot ulcers are one of the most important complications of diabetes and cause high rates of amputation. Diabetic hand infections are observed less frequently than foot infections. Hand infections related to diabetes have mostly

Read more

21
Feb

New center in Abu Dhabi

BioBarica opened a new center in Abu Dhabi. Ibrahim Shehata, the sales coordinator of the region, was present at the installation of the hyperbaric chamber and offered training to the staff that operates the unit. Hyperbaric chamber treatment is a non-invasive method that consists of supplying air and oxygen under pressure in a pressurized cabin at 1.4 atmospheres (ATM). The normal ambient atmospheric pressure is

Read more

21
Feb

The hyperbaric chamber: adjuvant of neurorehabilitation therapy

Stroke is the leading cause of disability in the world. It is estimated that of the 15 million people who have suffered one, 5 million have been left with permanent sequelae, such as motor, sensory disorders, urinary incontinence, speech alteration, and understanding, etc. “When a stroke occurs, the time to apply a treatment to return the blood supply and the

Read more

14
Feb

Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis

Hyperbaric oxygen has been used in patients with rheumatic disease for many years without reports of untoward or unusual complications for a variety of non-rheumatic indications. Recent evidence that hyperbaric oxygen inhibits the actions of certain cytokines, acts as an immune modulator and may help cognitive dysfunction has resulted in a re-examination of its potential role in rheumatic diseases. This

Read more

6
Feb

Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies

One of the major issues contributing to the ineffective medical treatment of cancer is the occurrence of local hypoxia within the central tumor areas. The application of hyperbaric oxygen therapy (HBOT) may help overcome the problem of oxygen deficiency in the poorly oxygenated regions of the neoplastic tissue. To date, several reviews on the use of HBO in cancer treatment

Read more

31
Jan

Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments

Painful bladder syndrome/interstitial cystitis (PBS/IC) is a collective term covering a range of clinical complaints and pathological findings. Approximately 10-50% of PBS/IC patients demonstrate a classical mucosal ulcer (Hunner’s ulcer), and the majority are diagnosed on the basis of positive factors and exclusions derived from the diagnostic criteria of the National Institute of Diabetes and Digestive and Kidney Diseases for

Read more